Skip to main content
Evidence-Based Supplement Research
Evidence-Based Supplement Research
Pillser
Search
Sign UpLog In

Morus alba L. for Blood Sugar Management: A Systematic Review and Meta-Analysis.

  • 2022-05-23
  • Evidence-based complementary and alternative medicine : eCAM 2022
    • Hye In Jeong
    • Soobin Jang
    • Kyeong Han Kim

Study Design

Type
Review
Methods
Systematic review following PRISMA-P, searching PubMed, EMBASE, and four Korean medical databases (RISS, OASIS, NDSL, and KISS), including randomized controlled trials with any type of control intervention; selection, data extraction, and quality assessment performed independently by two researchers.

Introduction

Morus alba L. is used for blood sugar management in patients with diabetes mellitus. This review aimed to evaluate the effect of Morus alba on blood sugar management.

Methods

This review was conducted in accordance with the Preferred Reporting Items for Systematic Review and Meta-Analysis Protocols (PRISMA-P). We searched PubMed, EMBASE, and four Korean medical databases (RISS, OASIS, NDSL, and KISS) using relevant keywords. Randomized controlled trials with any type of control intervention were included. The selection of studies, data extraction, and quality assessment were performed independently by two researchers.

Results

Our results showed that Morus alba can reduce postprandial glucose and insulin levels. However, it is insufficient to conclude that Morus alba is an effective intervention for lowering blood glucose levels. Therefore, more rigorous studies are needed to reveal the effect of MA on blood glucose levels.

Conclusion

The conclusion of this review provides evidence that Morus alba can control blood sugar level. This systematic review was registered with the International Prospective Register of Systematic Reviews (PROSPERO) (CRD42021255940).

Research Insights

Back to top